Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Schukro, C; Santer, D; Prenner, G; Stühlinger, M; Martinek, M; Teubl, A; Moertl, D; Schwarz, S; Nürnberg, M; Fiedler, L; Hatala, R; Khazen, C.
State-of-the-art consensus on non-transvenous implantable cardioverter-defibrillator therapy.
Clin Cardiol. 2020; 43(10):1084-1092
Doi: 10.1002/clc.23432
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Prenner Günther
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Within the last decade, implantable cardioverter-defibrillator (ICD) systems with non-transvenous leads were developed in order to minimize complications related to the cardiovascular position of transvenous ICD leads. This national expert consensus gives an overview of potential indications for the implantation of non-transvenous ICD systems, and provides specific recommendations for implantation, follow-up, and complication management in patients with subcutaneous ICD. Regarding particular issues like the necessity for shock efficacy testing, or the clinical outcome as compared to transvenous ICD, randomized data are expected in the near future. © 2020 The Authors. Clinical Cardiology published by Wiley Periodicals LLC.
- Find related publications in this database (Keywords)
- consensus document
- non-transvenous implantable cardioverter defibrillator
- recommendations
- subcutaneous implantable cardioverter defibrillator